Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.005 Å; R factor = 0.034; wR factor = 0.077; data-to-parameter ratio = 15.0.
In title compound, [Sn(C 6 H 5 ) 3 (C 9 H 6 BrN 2 OS 2 )], the Sn atom is five-coordinated and the 1,3,4-thiadiazole-2-thiol ligand acts as an S,N-bidentate chelating ligand. The five-coordinate Sn IV atom forms four primary bonds, three to the phenyl groups and one to the S atom. Thus, the title complex has a distorted cis-trigonal bipyramidal geometry with the S atom and two C atoms occupying the equatorial plane, whereas the N atom and another C atom are in axial positions. In addition, there is a weak intramolecular SnÁ Á ÁN interaction. The crystal structure involves weak intramolecular C-HÁ Á ÁN and intermolecular C-HÁ Á ÁBr hydrogen bonding.
Related literature
For the biological activity of 1,3,4-thiadiazole compounds, see: Oruc et al. (2004) ; Sawhney & Sharma (1993) ; Srivastava & Pandey (1993) . For the biological activity of organotin(IV) compounds, see: Jimenez-Perez et al. (2000) . For related crystal structures, see: Ma et al. (2006) ; Ng et al. (1990) ; Rodarte de Moura et al. (1999) .
Experimental
Crystal data [Sn(C 6 Hydrogen-bond geometry (Å , ). Data collection: CrystalClear (Rigaku, 2005) ; cell refinement: CrystalClear (Rigaku, 2005) ; data reduction: CrystalClear (Rigaku, 2005) ; program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXTL (Sheldrick, 2008) .
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HG2497).
[5-(4-Bromophenoxymethyl)-1,3,4-thiadiazole-2-thiolato]triphenyltin(IV) Z. Wang, G. Zhao and L. Tian (Oruc et al., 2004; Sawhney & Sharma, 1993; Srivastava & Pandey, 1993) . Meanwhile, organotins (IV) have been well known for their biological activities (Jimenez-Perez et al., 2000) . In order to find a new compound with broad spectrum of bioactivity we have designed and synthesized the title compound.
The title compound, bond lengths and angles are normal and in a good agreement with those reported previously (Ma et al., 2006; Ng et al., 1990) . The five coordinated tin atoms forms four primary bonds: three to the phenyl groups and one to the sulfur atom. In addition, there is a weak intramolecular Sn···N interaction, the Sn1···N1 bond length (2.92 (2) Å) is longer than the sum of covalent radii (2.15 Å), but is shorter than that reported in Ph 3 Sn(MBZ) (3.07 Å) (Rodarte de Moura et al., 1999) . So the ligand 1,3,4-thiadiazole-2-thiol acts as a bidentate S, N chelating ligand. The crystal structure involves weak intramolecular C-H···N and intermolecular C-H···Br hydrogen bonding.
Experimental 5-[(4-Bromophenoxy)methyl]-2-mercapto-1,3,4-thiadiazole (0.31 g, 1 mmol) and Ph 3 SnCl (0.385 g, 1 mmol) were dissolved in 30 ml of toluene, and the resultant mixture was heated to reflux for 6 h. The solvent was removed on a rotary evaporator, and the residue was heated in 50 ml of boiling dichloromethane/absolute ethanol (1/1 by volume). The solution was cooled to room temperature and then filtered, and the filtrate was evaporated slowly at room temperature, from which the crystals suitable for the X-ray diffraction were thus obtained.
Refinement
All H atoms were found on difference maps, with C-H = 0.93 or 0.97 and included in the final cycles of refinement using a riding model, with U iso (H) = 1.2U eq (C). (11) C18-C13-Sn1 120.5 (2) C13-Sn1-C1 108.20 (12) C14-C13-Sn1 121.9 (3) C7-Sn1-C1 106.47 (12) C13-C14-C15 120.6 (4) C13-Sn1-S1 109.32 (9) C13-C14-H14 119.7
Hydrogen-bond geometry (Å, °) 
